Pluri PLUR
NASDAQ PLUR
$1.01 -0.02 (-1.94%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pluri (PLUR) Gains from Sales and Divestitures (2010 - 2017)

Updated

Pluri's Gains from Sales and Divestitures came in at -$6,000 for FY2018 (year ended Jun 30, 2018), compared with -$72,000 in FY2017.

Analysis

Pluri (PLUR) Gains from Sales and Divestitures (2010 - 2017) Analysis & Trends

Going back to FY2011, Pluri's Gains from Sales and Divestitures data covers 7 fiscal years.

  • The FY2018 figure represents the highest annual Gains from Sales and Divestitures since FY2012.
  • Per Business Quant, earlier fiscal years put Gains from Sales and Divestitures at -$72,000 in FY2017, -$82,000 in FY2016, -$20,000 in FY2015 and -$85,000 in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Pluri 10.93 Mn -1.84 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 -77,000.00
Mar 31, 2017 1,000.00
Sep 30, 2016 4,000.00
Jun 30, 2016 -85,000.00
Mar 31, 2016 2,000.00
Dec 31, 2015 -2,000.00
Sep 30, 2015 3,000.00
Jun 30, 2014 -50,000.00
Sep 30, 2010 -8,000.00
API Access

Pluri Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=PLUR&period=max&api_key=YOUR_API_KEY